Less Is More: A Case of Isolated Kidney Transplantation with Lumasiran in Primary Hyperoxaluria Type 1

被引:0
|
作者
Ice, Alissa Angelica [1 ]
Azam, Muhammad Jibran [1 ]
Langone, Anthony J. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源
关键词
D O I
10.1681/ASN.20242axrpkcd
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
TH-PO767
引用
收藏
页数:2
相关论文
共 50 条
  • [21] The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants
    Meaux, Marie-Noelle
    Sellier-Leclerc, Anne-Laure
    Acquaviva-Bourdain, Cecile
    Harambat, Jerome
    Allard, Lise
    Bacchetta, Justine
    PEDIATRIC NEPHROLOGY, 2022, 37 (04) : 907 - 911
  • [22] Infantile Primary Hyperoxaluria Type 1 Treated With Lumasiran in Twin Males
    Aldabek, Khaled
    Grossman, Oulimata K.
    AL-Omar, Osama
    Fox, Janelle A.
    Moritz, Michael L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [23] Lumasiran for primary hyperoxaluria type 1: What we have learned?
    Gang, Xuan
    Liu, Fei
    Mao, Jianhua
    FRONTIERS IN PEDIATRICS, 2023, 10
  • [24] Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1
    Hulton, Sally-Anne
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (7-10): : 189 - 198
  • [25] Liver-kidney-transplantation in type 1 primary hyperoxaluria: description and comments on a case
    Gambaro, G
    Lidestri, V
    Gerunda, GE
    Zavan, MC
    Iemmolo, RM
    Rigotti, P
    Naso, A
    Antonello, A
    D'Angelo, A
    CLINICAL NEPHROLOGY, 2000, 53 (04) : B35 - B37
  • [26] Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2
    Naderi, GholamHossein
    Latif, AmirHossein
    Tabassomi, Firouzeh
    Esfahani, Seyed Taher
    PEDIATRIC TRANSPLANTATION, 2014, 18 (03) : E69 - E73
  • [27] Primary Hyperoxaluria Diagnosed After Second Kidney Transplantation and Treated With Lumasiran: Never Say Never!
    Sarkar, Mrinalini
    Kendrick, Elizabeth A.
    Lum, Erik L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 838 - 838
  • [28] Modeling the Risk of Progression to Kidney Failure in Patients with Primary Hyperoxaluria Type 1 Treated with Lumasiran Relative to a Natural History Cohort Not Treated with Lumasiran
    Lieske, John C.
    Mara, Kristin C.
    Danese, David S.
    Gansner, John M.
    Lu, Jiandong
    Milliner, Dawn S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 422 - 422
  • [29] STABLE EGFR IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 TREATED WITH LUMASIRAN, REGARDLESS OF KIDNEY FUNCTION AT START OF TREATMENT
    Hayes, Wesley
    Garrelfs, Sander
    Sas, David
    Lieske, John
    Ngo, Taylor
    Gansner, John
    McGregor, Tracy
    Frishberg, Yaacov
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 113 - 113
  • [30] Variable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1
    Saffe, Sina
    Doerry, Katja
    Buscher, Anja K.
    Hansen, Matthias
    Rohmann, Melanie
    Kanzelmeyer, Nele
    Latta, Kay
    Kemper, Markus J.
    Loos, Sebastian
    PEDIATRIC NEPHROLOGY, 2025, : 1929 - 1937